.png){kind=icon}
返回
Microbiome-based therapeutics
.png){kind=icon}
PRE
AI
DOI：10.1038/s41579-021-00667-9.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Microbiome-based therapeutics hold great promise for reducing disease susceptibility and enhancing disease resistance. In this Review, Sorbara and Pamer explore the major bacterial phyla associated with health benefits and the potential of microbiome-based therapeutics, including faecal microbiota transplantation, bacterial consortia, engineered symbiotic bacteria, diet and prebiotics, and microbiome-derived proteins and metabolites. They also discuss the challenges confronting therapeutic development as well as the regulatory hurdles for clinical trials and manufacturing. Symbiotic microorganisms inhabiting the gastrointestinal tract promote health by decreasing susceptibility to infection and enhancing resistance to a range of diseases. In this Review, we discuss our increasing understanding of the impact of the microbiome on the mammalian host and recent efforts to culture and characterize intestinal symbiotic microorganisms that produce or modify metabolites that impact disease pathology. Manipulation of the intestinal microbiome has great potential to reduce the incidence and/or severity of a wide range of human conditions and diseases, and the biomedical research community now faces the challenge of translating our understanding of the microbiome into beneficial medical therapies. Our increasing understanding of symbiotic microbial species and the application of ecological principles and machine learning are providing exciting opportunities for microbiome-based therapeutics to progress from faecal microbiota transplantation to the administration of precisely defined and clinically validated symbiotic microbial consortia that optimize disease resistance.
Keyword:
HUMAN GUT BACTERIA
ACTIVE ULCERATIVE-COLITIS
ARYL-HYDROCARBON RECEPTOR
CHAIN FATTY-ACIDS
INTESTINAL MICROBIOTA
COLONIZATION RESISTANCE
DIFFICILE INFECTION
INTERSPECIES COMPETITION
DIETARY FIBER
DONOR FECES
期刊
N
IF:
103.3
论文数:
3.6K
被引数:
6.1W
机构
引用论文
Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysm前壁左心室室壁瘤的左心室重建手术的早期血流动力学结果
PREAI
分享收藏Intravenous Cocaine Induces Platelet Activation in the Conscious Dog静脉注射可卡因诱导清醒犬的血小板活化.png)
Circulation
CirculationIF0
PREAI
分享收藏分享收藏Proteobacteria: microbial signature of dysbiosis in gut microbiota变形杆菌: 肠道菌群生态失调的微生物特征TRENDS IN BIOTECHNOLOGY
TRENDS IN BIOTECHNOLOGYIF14.9
PREAI
分享收藏Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis肠道普雷沃氏菌的扩张与对关节炎的敏感性增强相关ELIFE
OAAI
ELIFEIF0
OAAI分享收藏分享收藏
查看更多内容